Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

BACKGROUND: As trials of 5 years of tamoxifen in early breast cancer mature, the relevance of hormone receptor measurements (and other patient characteristics) to long-term outcome can be assessed increasingly reliably. We report updated meta-analyses of the trials of 5 years of adjuvant tamoxifen....

Descripción completa

Detalles Bibliográficos
Autor principal: Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lancet Publishing Group 2011
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163848/
https://www.ncbi.nlm.nih.gov/pubmed/21802721
http://dx.doi.org/10.1016/S0140-6736(11)60993-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163848/
https://www.ncbi.nlm.nih.gov/pubmed/21802721
http://dx.doi.org/10.1016/S0140-6736(11)60993-8

Ejemplares similares